UK recommendations for severe malaria are worrying

Sir Nicholas White; Nicholas Day; Arjen M. Dondorp; Nicholas M. Anstey

doi:10.1136/bmj.39143.014005.1f

Editorial Material2022

Severe Malaria, Pascalian Therapeutics, and the US Food and Drug Administration (FDA)

Sir Nicholas White, James A Watson, J. A. Simpson

Clinical Infectious Diseases

Editorial Material2011

Responding to the evidence for the management of severe malaria

Nathan Ford, Martin De Smet, Kavitha Kolappa, Sir Nicholas White

Tropical Medicine & International Health

Article2005

Artesunate versus quinine for treatment of severe falciparum malaria: a randomised trial

Arjen Dondorp, François Nosten, Kasia Stepniewska, Nick Day, Sir Nicholas White

The Lancet

Article2017

Defining Surrogate Endpoints for Clinical Trials in Severe Falciparum Malaria

Atthanee Jeeyapant, Hugh W. F. Kingston, Katherine Plewes, Richard J. Maude, Josh Hanson, Michael Herdman, Stije J. Leopold, Thatsanun Ngernseng, Prakaykaew Charunwatthana, Nguyen Hoan Phu, Aniruddha Ghose, Md Mahtab Uddin Hasan, Caterina Fanello, Md Abul Faiz, Tran Tinh Hien, Nicholas Day, Sir Nicholas White, Arjen M. Dondorp

PLoS ONE

Article1987

HYPOGLYCAEMIA IN AFRICAN CHILDREN WITH SEVERE MALARIA

Sir Nicholas White, Kevin Marsh, R. C. Turner, Kirk D. Miller, C. Berry, D H Williamson, Judith Brown

The Lancet

UK recommendations for severe malaria are worrying

Abstract

Discussion(0)

Related publications

Severe Malaria, Pascalian Therapeutics, and the US Food and Drug Administration (FDA)

Responding to the evidence for the management of severe malaria

Artesunate versus quinine for treatment of severe falciparum malaria: a randomised trial

Defining Surrogate Endpoints for Clinical Trials in Severe Falciparum Malaria

HYPOGLYCAEMIA IN AFRICAN CHILDREN WITH SEVERE MALARIA